| Date | Title | Description | Source |
| 02.05.2024 | Everest Medicines Announces Hong Kong Department of Health A... | SHANGHAI, May 2, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the &... | en.prnasia... |
| 28.03.2024 | Everest Medicines Announces Financial Results for Full Year ... | SHANGHAI, March 28, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or th... | en.prnasia... |
| 20.03.2024 | Everest Medicines Announces Singapore Health Sciences Author... | SHANGHAI, March 20, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or th... | en.prnasia... |
| 18.03.2024 | Everest Medicines Strengthens Management Team with Appointme... | SHANGHAI, March 18, 2024 /PRNewswire/ -- Everest Medicines (HKEX: 1952.HK, "Everest," or t... | en.prnasia... |
| 12.03.2024 | Everest Medicines' Partner Calliditas Therapeutics Announces... | SHANGHAI, March 12, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or th... | en.prnasia... |
| 11.03.2024 | Everest Medicines Announces Acceptance of VELSIPITY® New Dru... | -- Macau is on course to become the first of Everest's Asian territories to get etrasimod approval
-... | en.prnasia... |
| 06.03.2024 | Everest Medicines to Announce Full-Year 2023 Financial Resul... | SHANGHAI, March 6, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the... | en.prnasia... |
| 27.02.2024 | Everest Medicines and Kezar Life Sciences Receive IND Approv... | SHANGHAI, China and SOUTH SAN FRANCISCO, Calif., Feb. 27, 2024 /PRNewswire/ -- Everest Medicines (HK... | en.prnasia... |
| 22.02.2024 | Everest Medicines' Partner Pfizer Announces European Commiss... | --VELSIPITY is the first and only oral advanced ulcerative colitis therapy approved for use in patie... | en.prnasia... |
| 21.02.2024 | Everest Medicines' Licensing Partner Venatorx Pharmaceutical... | --Cefepime-taniborbactam was superior to meropenem for the composite efficacy endpoint with composit... | en.prnasia... |
| 19.02.2024 | Everest Medicines Announces Termination of Collaboration Agr... | -Everest will continue to develop self-discovered products utilizing the mRNA platform-
SHANGHAI, Fe... | en.prnasia... |
| 22.01.2024 | Everest Medicines Announces 2023 Revenue Expected to be Betw... | SHANGHAI, Jan. 22, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the... | en.prnasia... |
| 21.12.2023 | Everest Medicines' Partner Calliditas Therapeutics Announces... | SHANGHAI, Dec. 21, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the... | en.prnasia... |
| 04.12.2023 | Everest Medicines Announces Investigational New Drug Applica... | -- Everest plans to contribute to the ongoing global Phase 2b PALIZADE trial of zetomipzomib in acti... | en.prnasia... |
| 01.12.2023 | Everest Medicines Announces Positive Topline Results from In... | --Clinically meaningful and statistically significant results demonstrated for primary endpoint and ... | en.prnasia... |
| 30.11.2023 | Everest Medicines Announces Acceptance of Nefecon® New Drug ... | SHANGHAI, Nov. 30, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the... | en.prnasia... |
| 24.11.2023 | Everest Medicines Announces China NMPA's Approval of Nefecon... | --Nefecon® is the first approved medicine with an IgAN indication in China--
--The approval marks a ... | en.prnasia... |
| 27.10.2023 | Everest Medicines Announces Poster Presentation at ASN Kidne... | SHANGHAI, Oct. 27, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the... | en.prnasia... |
| 27.10.2023 | Everest Medicines Announces New Drug Application Approval by... | SHANGHAI, Oct. 27, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest," or the... | en.prnasia... |
| 16.10.2023 | Everest Medicines' Licensing Partner Pfizer Announces U.S. F... | SHANGHAI, Oct. 16, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK) announced today that its li... | en.prnasia... |
| 05.10.2023 | Everest Medicines' Partner Calliditas Presents New Data from... | SHANGHAI, Oct. 5, 2023 /PRNewswire/ -- Everest Medicines' (HKEX 1952.HK, "Everest", or the... | en.prnasia... |
| 28.09.2023 | Everest Medicines Announces Approval of XERAVA® in Taiwan fo... | SHANGHAI, Sept. 28, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or th... | en.prnasia... |
| 21.09.2023 | Everest Medicines Enters into Collaboration and License Agre... | SHANGHAI, Sept. 21, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or th... | en.prnasia... |
| 20.09.2023 | Everest Medicines Announces China Center for Drug Evaluation... | SHANGHAI, Sept. 20, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical compa... | en.prnasia... |
| 25.08.2023 | Everest Medicines Announces New Drug Application Acceptance ... | SHANGHAI, Aug. 25, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the... | en.prnasia... |
| 24.08.2023 | Everest Medicines Announces Interim Results for First Half o... | SHANGHAI, Aug. 24, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the... | en.prnasia... |
| 21.08.2023 | Everest Medicines Announces Partner Calliditas Therapeutics ... | SHANGHAI, Aug. 21, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the... | en.prnasia... |
| 18.08.2023 | Everest Medicines' Partner Calliditas Therapeutics Announces... | SHANGHAI, Aug. 18, 2023 /PRNewswire/ -- Everest Medicines' (HKEX 1952.HK, "Everest", or th... | en.prnasia... |
| 15.08.2023 | Everest Medicines' Partner Venatorx Receives FDA Acceptance ... | SHANGHAI, Aug. 15, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK)'s partner Venatorx Pharmace... | en.prnasia... |
| 09.08.2023 | Everest Medicines to Announce First Half 2023 Financial Resu... | SHANGHAI, Aug. 9, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the ... | en.prnasia... |
| 01.08.2023 | Everest Medicines Announces Completion of Patient Enrollment... | SHANGHAI, August 1, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or th... | en.prnasia... |
| 27.07.2023 | Everest Medicines Announces Commercial Launch and First Pres... | Everest transforms into a commercial-stage innovative biopharmaceutical company
SHANGHAI, July 27, 2... | en.prnasia... |
| 21.06.2023 | Everest Medicines' Partner Calliditas Therapeutics Makes Dat... | SHANGHAI, June 21, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the... | en.prnasia... |
| 16.06.2023 | Everest Medicines Appoints Dr. Mike Berry as Chief Technolog... | SHANGHAI, June 16, 2023 /PRNewswire/ -- Everest Medicines (HKEX: 1952.HK, "Everest," or th... | en.prnasia... |
| 17.05.2023 | Everest Medicines Announces Completion of Patient Enrollment... | SHANGHAI, May 17, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the ... | en.prnasia... |
| 12.05.2023 | Nefecon Included in the Reimbursement Drug List of "Bei... | SHANGHAI, May 12, 2023 /PRNewswire/ -- An imported version of Nefecon (budesonide) delayed release c... | en.prnasia... |
| 24.04.2023 | Everest Medicines Launches Nefecon in China's Hainan Boao Pi... | SHANGHAI, April 24, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest," or th... | en.prnasia... |
| 19.04.2023 | Everest Medicines Announces Strategic Partnership with Shang... | SHANGHAI, April 19, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or th... | en.prnasia... |
| 06.04.2023 | Everest Medicines Announces New Drug Application Acceptance ... | Nefecon NDA is currently under Priority Review in China and expected to receive approval in 2H 2023
... | en.prnasia... |
| 31.03.2023 | Everest Medicines Announces Financial Results for Full Year ... | SHANGHAI, March 30, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or th... | einpresswi... |
| 31.03.2023 | Everest Medicines Announces Financial Results for Full Year ... | SHANGHAI, March 31, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or th... | en.prnasia... |
| 27.03.2023 | Everest Medicines Receives Full Upfront Payment from Gilead ... | SHANGHAI, March 27, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical compa... | en.prnasia... |
| 27.03.2023 | Everest Medicines Receives Full Upfront Payment from Gilead ... | SHANGHAI, March 26, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical compa... | einpresswi... |
| 23.03.2023 | Everest Medicines Announces Signing of an MOU for Strategic ... | GUANGZHOU, China, March 23, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest"... | en.prnasia... |
| 15.03.2023 | Everest Medicines to Announce Full-Year 2022 Financial Resul... | SHANGHAI, March 15, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical compa... | en.prnasia... |
| 14.03.2023 | Everest Medicines Announces Partner Calliditas Therapeutics ... | SHANGHAI, March 14, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or th... | en.prnasia... |
| 14.03.2023 | Everest Medicines Announces Partner Calliditas Therapeutics ... | SHANGHAI, March 13, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or th... | einpresswi... |
| 13.03.2023 | Everest Medicines Announces Silicon Valley Bank Developments... | SHANGHAI, March 12, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical compa... | einpresswi... |
| 13.03.2023 | Everest Medicines Announces Silicon Valley Bank Developments... | SHANGHAI, March 13, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical compa... | en.prnasia... |
| 28.02.2023 | Everest Medicines Hosts Ceremony to Celebrate Commencement o... | SHANGHAI, Feb. 28, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest" or the ... | en.prnasia... |
| 10.02.2023 | Everest Medicines Announces South Korea Grants Fast Track Re... | SHANGHAI, Feb. 10, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical compan... | en.prnasia... |
| 18.01.2023 | Everest Medicines Announces Top-line Data from Phase I Study... | Study findings suggest that EVER206 is well-tolerated with no new safety signals, supporting next-ph... | en.prnasia... |
| 03.01.2023 | Everest Medicines Announces New Strategic Plans, Reinforcing... | --Focus on renal disease and mRNA platform portfolios--
--Build out commercialization capabilities i... | en.prnasia... |
| 30.12.2022 | Everest Medicines Announces China NMPA Recommends Priority R... | --Further regulatory support for accelerated approval of Nefecon following NMPA's NDA acceptance wit... | en.prnasia... |
| 30.12.2022 | Everest Medicines Announces China NMPA Recommends Priority R... | --Further regulatory support for accelerated approval of Nefecon following NMPA's NDA acceptance wit... | einpresswi... |
| 30.12.2022 | Everest Medicines to Hold New Corporate Strategy Online Conf... | SHANGHAI, Dec. 29, 2022 /PRNewswire/ -- Everest Medicines (HKEX: 1952), a biopharmaceutical company ... | einpresswi... |
| 30.12.2022 | Everest Medicines to Hold New Corporate Strategy Online Conf... | SHANGHAI, Dec. 30, 2022 /PRNewswire/ -- Everest Medicines (HKEX: 1952), a biopharmaceutical company ... | en.prnasia... |
| 28.12.2022 | Everest Medicines Commences Operations at its mRNA Vaccine M... | --Everest owns complete pharmaceutical and vaccine value chain from discovery, clinical development,... | einpresswi... |
| 28.12.2022 | Everest Medicines Commences Operations at its mRNA Vaccine M... | --Everest owns complete pharmaceutical and vaccine value chain from discovery, clinical development,... | en.prnasia... |
| 22.12.2022 | Everest Medicines' Licensing Partner Pfizer Announces FDA an... | SHANGHAI, Dec. 22, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK) announced today that its li... | en.prnasia... |
| 15.12.2022 | Everest Medicines Announces New mRNA Rabies Vaccine Program ... | Rabies program, as the first non-COVID19 vaccine developed with a specialized mRNA platform, highlig... | en.prnasia... |
| 28.11.2022 | Everest Medicines Announces Major Regulatory Updates in Taiw... | -- Taiwan Food and Drug Administration grants Accelerated Approval Designation (AAD) to Nefecon --
-... | en.prnasia... |
| 15.11.2022 | Everest Medicines Announces New Drug Application Acceptance ... | -- NDA acceptance takes Everest closer to making this first-in-disease treatment available for prima... | en.prnasia... |
| 19.10.2022 | Everest Medicines Announces Partner Providence Reports Posit... | -- Levels of neutralizing antibodies generated by PTX-COVID19-B were non-inferior to Comirnaty®--
--... | en.prnasia... |
| 26.09.2022 | Everest Medicines Receives Approval of Investigational New D... | Advancement highlights Everest's potential in providing first-in-class therapies to global patients ... | en.prnasia... |
| 19.09.2022 | Everest Medicines Appoints Rogers Yongqing Luo as Chief Exec... | SHANGHAI, Sept. 19, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or th... | en.prnasia... |
| 26.08.2022 | Everest Medicines Announces the Departure of CEO, Kerry Blan... | SHANGHAI, Aug. 26, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the... | en.prnasia... |
| 24.08.2022 | Everest Medicines Announces Interim Results for First Half o... | SHANGHAI, Aug. 24, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the... | en.prnasia... |
| 16.08.2022 | Everest Medicines Enters into Agreement with Gilead Sciences... | Everest to receive total considerations of up to $455 million with $280 million in upfront payments
... | einpresswi... |
| 16.08.2022 | Everest Medicines Enters into Agreement with Gilead Sciences... | Everest to receive total considerations of up to $455 million with $280 million in upfront payments
... | en.prnasia... |
| 11.08.2022 | Everest Medicines Announces Regulatory Update and Strategic ... | Taiwan FDA accepts New Drug Application for Xerava for treatment of cIAI
Everest enters into strateg... | en.prnasia... |
| 18.07.2022 | Everest Medicines Announces European Commission Grants Appro... | Kinpeygo® (developed under the name NEFECON) is the first and only EMA- approved treatment for IgAN
... | en.prnasia... |
| 10.06.2022 | Everest Medicines Announces Approval of Trodelvy® in China f... | – Trodelvy is Everest's First Product to Receive Regulatory Approval in China –
– Everest Plans to L... | en.prnasia... |
| 04.06.2022 | Everest Medicines' Licensing Partner Gilead Sciences Announc... | FOSTER CITY, Calif. and SHANGHAI, June 4, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK) anno... | en.prnasia... |
| 24.05.2022 | Everest Medicines' Licensing Partner Pfizer Presents ELEVATE... | SHANGHAI, May 24, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK) announced today that its lic... | en.prnasia... |
| 07.04.2022 | Everest Medicines Enters into an MOU for Partnership with Ch... | China Resources Pharmaceutical Group ("CR Pharma") intends to make strategic equity invest... | en.prnasia... |
| 06.04.2022 | Everest Medicines Announces that Topline Results from Chines... | SHANGHAI, April 6, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical compan... | en.prnasia... |
| 31.03.2022 | Everest Medicines Submits New Drug Application in Hong Kong ... | SHANGHAI, March 31, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical compa... | en.prnasia... |
| 30.03.2022 | Everest Medicines Announces that Licensing Partner Pfizer Re... | SHANGHAI, March 30, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK) announced today that its l... | en.prnasia... |
| 29.03.2022 | Everest Medicines Announces Financial Results for Full Year ... | SHANGHAI, March 29, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or th... | en.prnasia... |
| 15.03.2022 | Everest Medicines to Announce Full-Year 2021 Financial Resul... | SHANGHAI, March 15, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or th... | en.prnasia... |
| 14.03.2022 | Everest Medicines Enters into Agreement with Calliditas Ther... | SHANGHAI, March 14, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical compa... | en.prnasia... |
| 10.03.2022 | Everest Medicines Announces that Licensing Partner Venatorx ... | SHANGHAI, March 10, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK) announced today that its l... | en.prnasia... |
| 07.02.2022 | Everest Medicines Announces First Drug Approval of Trodelvy®... | SHANGHAI, Feb. 7, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the ... | en.prnasia... |
| 14.01.2022 | Everest Medicines Enters into a Global Licensing Agreement t... | SHANGHAI, Jan. 14, 2022 /PRNewswire/ -- Everest Medicines(HKEX 1952.HK, "Everest", or the ... | en.prnasia... |
| 10.01.2022 | Everest Medicines Will Participate in a Clinical Trial with ... | SHANGHAI, Jan. 10, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the... | en.prnasia... |
| 04.01.2022 | Everest Medicines Announces Taiwan FDA Has Accepted New Drug... | SHANGHAI, Jan. 4, 2022 /PRNewswire/ -- Everest Medicines Limited (HKEX 1952.HK, "Everest",... | en.prnasia... |
| 20.12.2021 | Everest Medicines and Providence Therapeutics announces that... | SHANGHAI, Dec. 20, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK) and Providence Therapeutics... | en.prnasia... |
| 16.12.2021 | Everest Medicines announces FDA grants our Partner Callidita... | TARPEYO (budesonide) delayed release capsules is the first and only treatment indicated to reduce pr... | en.prnasia... |
| 15.12.2021 | Everest Medicines Announces the Acceptance of a New Drug App... | SHANGHAI, Dec. 15, 2021 /PRNewswire/ -- Everest Medicines Limited (HKEX 1952.HK, "Everest"... | en.prnasia... |
| 01.12.2021 | Everest Medicines and Providence Therapeutics Jointly Announ... | SHANGHAI and CALGARY, Canada, Dec. 1, 2021 /PRNewswire/ -- Everest Medicines and Providence Therapeu... | en.prnasia... |
| 24.11.2021 | Everest Medicines Announces Inclusion in the MSCI Global Sma... | SHANGHAI, Nov. 23, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest" or the ... | marketscre... |
| 24.11.2021 | Everest Medicines Announces Inclusion in the MSCI Global Sma... | SHANGHAI, Nov. 24, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest" or the ... | en.prnasia... |
| 11.11.2021 | Everest Medicines and Gilead Sciences Jointly Announce Phase... | SHANGHAI, Nov. 11, 2021 /PRNewswire/ -- Everest Medicines and Gilead Sciences, Inc. (Nasdaq: GILD) j... | en.prnasia... |
| 08.11.2021 | Everest Medicines Announces Up to HK$100 million Additional ... | SHANGHAI, Nov. 7, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest" or the &... | marketscre... |
| 08.11.2021 | Everest Medicines Announces Up to HK$100 million Additional ... | SHANGHAI, Nov. 8, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest" or the &... | en.prnasia... |
| 01.11.2021 | Everest Medicines Announces Share Repurchase Transaction Det... | SHANGHAI, Nov. 1, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest" or the &... | en.prnasia... |
| 01.11.2021 | Everest Medicines Announces Share Repurchase Transaction Det... | SHANGHAI, Oct. 31, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest" or the ... | marketscre... |
| 29.09.2021 | Everest Medicines Initiates Submission of New Drug Applicati... | SHANGHAI, Sept. 29, 2021 /PRNewswire/ -- Everest Medicines Limited (HKEX 1952.HK, "Everest"... | en.prnasia... |
| 24.09.2021 | Everest Medicines : Announces Approval of Investigational Ne... | SHANGHAI, Sept. 24, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical compa... | marketscre... |
